iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Share-Based Compensation (Tables)

Share-Based Compensation (Tables)

6 Months Ended

Dec. 31, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

The following table summarizes the components of share-based compensation expense in the condensed consolidated statements of operations (in thousands):

	Three Months Ended
	December 31,
	2014		2013
Research and development	$	(20)	$	20
General and administrative		233		255
Totals	$	213	$	275

	Six Months Ended
	December 31,
	2014		2013
Research and development	$	-	$	38
General and administrative		466		472
Totals	$	466	$	510

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

The following table summarizes all stock option activity during the six months ended December 31, 2014:

					Weighted-
			Weighted-		average
			average		Remaining		Aggregate
	Stock		Exercise		Contractual		Intrinsic Value
	Options		Price		Term (in years)		(in thousands)
Outstanding as of June 30, 2014		8,483,334	$	1.25		7.0	$	179
Granted		1,740,000	$	0.88
Forfeited		(500,000)		0.87
Outstanding as of December 31, 2014		9,723,334	$	1.20		7.1	$	865
Vested and expected to vest as of December 31, 2014		9,634,999	$	1.45		7.1	$	865

Exercisable as of December 31, 2014		5,836,683	$	1.45		6.0	$	513